raphy (PET)5,6sa powerful noninvasive method for molec-
ular imagingsof a living rhesus monkey,7 using tritium- and
11C-labeled TIC derivatives, respectively. 15-Deoxy-TIC (1)
has shown binding to the CNS-type IP2 receptor (IC50 ) 3
nM) 10 times stronger than its 15R-TIC counterpart. Fur-
thermore, the ratio of the potency of the binding affinity
between 15-deoxy-TIC (1) and 15R-TIC (2) is actually
correlated well with the biological activity. 15-Deoxy-TIC
(1) has also shown an inhibitory effect on apoptosis of
neuronal cells induced by high oxygen (50%) atmosphere
at 10-fold lower concentration than 15R-TIC (2) (IC50 ) 30
and 300 nM), respectively.8
carbacyclin (5) and 3-thiaisocarbacyclin (6)sby appropriate
choice of R-side-chain Grignard reagent. The second key
step in our synthetic stategy is the generation of the five-
ring endocyclic double bond. Previous work has been carried
out on the desymmetrization of such bicyclic systems;13 all,
to the best of our knowledge, have employed the use of a
chiral base. As we were first looking for a cost-efficient
synthesis, available on gram scale, and one that avoided the
use of an expensive chiral base, we envisaged that vinyl
triflate 8a could be synthesized via the regioselective
deprotonation of the corresponding ketone under substrate
control. To these ends we chose the sterically demanding
trityl protecting group on the premise that due to the roof-
shaped structure of ketone 9, it would hinder the approach
of the base at C7, leaving C9R open for deprotonation.
Ketone 9 could then in turn be easily obtained in gram
quantities from the known bicyclic methyl ester 10,14 with a
mimimum of synthetic transformations.
Scheme 1
Scheme 2
Our retrosynthesis of 15-deoxy-TIC (1) (Scheme 1)
features the late-stage construction of the C13-C14 double
bond in the ω-side chain by the Julia-Kocien˜ski olefination.
The attachment of the R-side chain (C1-C5 skeleton) and
construction of the C6-C9R9 double bond has always proven
to be a stumbling block and, as such, has received great
attention over the years.10-12 We decided that a disconnection
at C5-C6 could exploit an sp2-sp3 palladium-catalyzed
cross-coupling approach between vinyl triflate 8a, and
primary alkyl Grignard reagent 12, to install the required
R-side chain. This approach would also allow flexibility for
the synthesis of other isocarbacyclin derivativess3-oxaiso-
Starting from methyl ester 10, after treatment with TBSCl
and reduction with DIBAL-H, primary alcohol 11 was
obtained (Scheme 2). Cleavage of the ketal protecting group
and subsequent tritylation of the primary alcohol, ketone 9
was obtained in 89% yield over four steps.
Scheme 3
(5) Suzuki, M.; Noyori, R.; Långstro¨m, B.; Watanabe, Y. Bull. Chem.
Soc. Jpn. 2000, 73, 1053.
(6) Suzuki, M.; Doi, H.; Hosoya, T.; Långstro¨m, B.; Watanabe, Y. Trends
Anal. Chem. 2004, 23, 595 and references therein.
(7) Watanabe, Y.; Suzuki, M.; Bjo¨rkman, M.; Matsumura, K.; Watanabe,
Y.; Kato, K.; Doi, H.; Onoe, H.; Sihver, S.; Andersson, Y.; Kobayashi, K.;
Inoue, O.; Hazato, A.; Lu, L.; Bergstro¨m, M.; Noyori, R.; Långstro¨m, B.
Abstr. Pap. Neuroimage, Aarhus, May 16-18, 1997; Vol. 5, A1.
(8) Satoh, T.; Ishikawa, Y.; Kataoka, Y.; Cui, Y.; Yanase, H.; Kato, K.;
Watanabe, Y.; Nakadate, K.; Matsumura, K.; Hatanaka, H.; Kataoka, K.;
Noyori, R.; Suzuki, M.; Watanabe, Y. Eur. J. Neurosci. 1999, 11, 3115.
(9) Prostacyclin numbering.
(10) Suzuki, M.; Koyano, H.; Noyori, R. J. Org. Chem. 1987, 52, 5583.
(11) Ogawa, Y.; Shibasaki, M. Tetrahedron Lett. 1984, 25, 1067.
(12) Ishikawa, T.; Ishii, H.; Shimizu, K.; Nakao, H.; Urano, J.; Kudo,
T.; Saito, S. J. Org. Chem. 2004, 69, 8133.
Ketone 9 in THF was treated with KHMDS (2 equiv) at
-108 °C and kept at this temperature for a further 2 h
followed by the addition of PhNTf2 in THF, giving an
inseparable mixture of compounds 8a and 8b (16:1 respec-
tivly from H NMR analysis) (Scheme 3). After recrystal-
lization, needles of triflate 8a were obtained which were then
1
5116
Org. Lett., Vol. 7, No. 23, 2005